Phase 2A clinical Trial – CFN Media

TRYP THERAPEUTICS RECEIVES CONFIRMATION FROM FDA TO PROCEED WITH PHASE 2A CLINICAL TRIAL IN PATIENTS WITH IBS AT MASSACHUSETTS GENERAL HOSPITAL

Kelowna Canada, (July 13 2023) — Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF)…

Ryan Allway
July 13, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

How to Invest in the LFP Electric Battery Boom

All electric cars, whether fully electric or hybrid, need some form of…

Robin Lefferts
November 6, 2024

Top News

Introducing LEEF Brands, Vertically Integrated California Powerhouse

The cannabis industry has fallen out of favor with many investors, in…

Ryan Allway
November 1, 2024

Aduro Clean Technologies Reports Fiscal 2025 First Quarter Results

LONDON, Ontario, Oct. 31, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies…

Ryan Allway
October 31, 2024

CEO.CA Interviews Stallion Uranium CEO

Stallion Uranium Corp. (TSX.V: STUD) (OTCQB: STLNF) (FSE: FE0) CEO Drew Zimmerman…

Ryan Allway
October 29, 2024